
Online now (open access) at Cell Reports: dlvr.it/TF7SjL


Online now (open access) at Cell Reports: dlvr.it/TF7SjL

Tremendous effort led by co-first authors Ethan Oxley (@MonashUni @Monash_FMNHS @MonashSTM @ACBDresearch) and Nadia Kershaw @drkersh (@WEHI_research). Thanks to co-authors including @CynthiaLouisDr, Ian Wicks, @Dr_Nick_Bikes @stephwiranata @emmye1984 @MeredithKeeffe

Our lab’s first foray into immunology examines how immunosuppressive CTLA4-Ig therapies like abatacept release PD-L1 from CD80. We show this effect depends on antigen-presenting cell surface CD80:PD-L1 ratio, and can reinforce T cell inhibition.


What an incredible Reunion! It was wonderful to see all former lab members who traveled to NYC from all over the world & to experience the joy that we all shared in getting together. THANK YOU & stay in touch! #LoweLab25

This is the league table of how countries are currently investing in R&D as a % of GDP. The figures continue a 14-year⬇️trend in national R&D investment for Australia. If we keep going the way we are, in 5yrs years we'll be among the lowest of all @OECD countries #Auspol2023
The Prime Minister @AlboMP acknowledged earlier this month that real, enduring reforms that change a country for the better take time. Investing more in R&D requires us to play the long game. But we must rush to get to the starting line. science.org.au/news-and-even…

Terrific @thecimminolab paper describing a new AML treatment approach – congratulations Luisa and crew!
We are thrilled to announce our new publication in @CellReports! Wonderful efforts from @john_brabson, @tiff_leesang, all the members of the Cimmino lab, and our collaborators @SylvesterCancer and @nyulangone. More to come in the near future.

Overcoming chemotherapy resistance in acute myeloid leukaemia nature.com/articles/s41375-0…

Thank you Scott! Loved those years at @CSHL, and great to see @LoweLabMSKCC going from strength to strength. A fantastic crew. Here’s to your next 25 years! #LoweLab25
Former postdoc Ross Dickins @CSHL developed a powerful gene regulation system that continues to produce impactful science. Back down under, @DickinsLab @ACBDresearch @MonashUni studies leukemia & immune checkpoints. He just visited us and presented amazing work! –SWL #LoweLab25

📢 New in @BloodCancerJnl! Researchers led by Dr. Christian Récher at @UT3PaulSabatier show that phenotypically-defined stages of #leukemia arrest 🚫 predict main driver mutation subgroups and outcomes in acute myeloid leukemia. Learn more: go.nature.com/3R55PKG

Pls retweet our main meeting for 2022, on 4-5 November!

Check out the fabulous speakers for our FREE 1-day Symposium. Register here: melbourneimmunotherapy.org/r…. Limited spaces are filling up fast…..so don’t delay!

Good to see PM pledging $2bn to commercialising research but we need to remember that without investment in basic research as well there will be nothing to commercialise.

Hugely appreciate this ASPIRE grant support from @TheMarkFdn to further our research into reducing relapse in acute myeloid leukaemia. A funding powerhouse with global impact. Thank you!
Congrats to Ross Dickins @DickinsLab @ACBDresearch @MonashUni @Monash_FMNHS & @ShomGoel @PeterMacCC on their #ASPIRE awards to support their #cancer research. This is the 1st time Oz projects have attracted @TheMarkFdn funding! monash.edu/medicine/news/lat…

New paper from our lab @NatureComms shows AML relapse after differentiation therapy can arise from persistent mature leukemia cells. Great effort from first author Steven Ngo and others including @kile_lab. Thanks to @ausrotaryhealth @LeukaemiaAus rdcu.be/cBdur

Great to see lab alumnus Matt starting his own lab in Colorado ... bring on some top science!
This tweet is unavailable